This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
Senior Vice President and Head of US Medical Specialties Business Unit
Lynn Fenicchia is Senior Vice President and Head of US Medical Specialties Business Unit at Astellas Pharma, Inc., responsible for leading Astellas’ US commercial activities for marketed products in the urology, anti-infectives and hospital business units. Lynn is a member of the Astellas US Management Committee.
Lynn has more than 25 years of experience in the pharmaceutical industry, with roles of increasing responsibility in the areas of sales leadership, marketing, strategy and operations. Lynn joined Yamanouchi Pharmaceutical Co., Ltd. in 2003, which merged with Fujisawa Pharmaceutical Co., Ltd. to create Astellas. Since joining Astellas, she has held multiple roles, including Vice President of Commercial Strategy and Operations, and Vice President of Sales, Urology Hospital.
Throughout her career, Lynn has participated in professional and industry organizations focused on leadership. She’s a member of the Healthcare Businesswomen’s Association (HBA) and was named an HBA Luminary Award winner in 2015 for her commitment to coaching and development.
Lynn graduated with Bachelor of Science degree in biology from East Carolina University, a Master of Science degree in exercise physiology from Syracuse University and a Master of Business Administration degree from the University of Notre Dame.